Point Capital, Inc. Intellectual Property Contracts & Agreements
7 Contracts & Agreements
- License Agreements (7 contracts)
- Exclusive License Agreement with Columbia University (Filed With SEC on July 8, 2024)
- Fourth Amendment to Master License Agreement (Filed With SEC on June 27, 2024)
- Third Amendment to Master License Agreement (Filed With SEC on November 14, 2023)
- First Amendment to Commercial Evaluation and License Agreement, dated July 6, 2021, by and between the Company and UMB (Filed With SEC on July 12, 2021)
- Amendment No. 1 to Patent License Agreement, dated April 12, 2021, by and among the Company, Silo Pharma, Inc. and AIkido Pharma Inc (Filed With SEC on April 16, 2021)
- Master License Agreement, dated February 12, 2021, by and between the Company and the University of Maryland, Baltimore (Filed With SEC on February 16, 2021)
- Patent License Agreement by and among the Company and Silo Pharma, Inc., a Florida corporation and their affiliates and subsidiaries and AIkido Pharma Inc (Filed With SEC on January 11, 2021)
